EPS Diluted (TTM) Chart

View EPS Diluted (TTM) for AXSM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (TTM) Chart
Start Trial

Historical EPS Diluted (TTM) Data

View and export this data back to 2015. Start Trial.
Date Value
June 30, 2026 -3.760
March 31, 2026 -3.739
December 31, 2025 -3.694
September 30, 2025 -4.673
June 30, 2025 -5.071
March 31, 2025 -5.769
December 31, 2024 -5.995
September 30, 2024 -6.536
June 30, 2024 -6.514
March 31, 2024 -6.385
December 31, 2023 -5.200
September 30, 2023 -4.526
June 30, 2023 -4.280
March 31, 2023 -3.802
December 31, 2022 -4.579
September 30, 2022 -4.069
June 30, 2022 -3.920
March 31, 2022 -3.718
December 31, 2021 -3.466
September 30, 2021 -3.347
June 30, 2021 -3.036
March 31, 2021 -2.671
Date Value
December 31, 2020 -2.766
September 30, 2020 -2.699
June 30, 2020 -2.640
March 31, 2020 -2.553
December 31, 2019 -1.998
September 30, 2019 -1.606
June 30, 2019 -1.365
March 31, 2019 -1.279
December 31, 2018 -1.145
September 30, 2018 -1.134
June 30, 2018 -1.090
March 31, 2018 -1.068
December 31, 2017 -1.29
September 30, 2017 -1.36
June 30, 2017 -1.47
March 31, 2017 -1.53
December 31, 2016 -1.43
September 30, 2016 -1.17
June 30, 2016 -0.79
March 31, 2016 -0.43
December 31, 2015 -0.12

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Eli Lilly & Co. 29.43
Liquidia Corp. 1.364
Filana Therapeutics, Inc. -0.8753
CorMedix, Inc. 2.105
Eloxx Pharmaceuticals, Inc. -8.276